Compugen First Quarter 2008 Conference Call to Be Held 10:00 AM EDT Wednesday, May 14, 2008

  
    
  
  
    
      Compugen Ltd. (NASDAQ:CGEN) today announced that the Company plans to 
      host a live conference call and webcast at 10:00 AM EDT on Wednesday, 
      May 14, 2008 to review the first quarter of 2008. The financial results 
      for the quarter will be released prior to the conference call.
    
    
      To access the conference call, please dial 1-888-407-2553 from the US or 
      [phone] internationally. The call will also be available via 
      live webcast through Compugen’s Website, 
      located at www.cgen.com.
    
    
      A replay of the conference call will be available approximately two 
      hours after the completion of the live conference call. To access the 
      replay, please dial 1-877-456-0009 from the US or [phone]. 
      The replay will be available until 12 noon EDT on May 17, 2008.
    
    
      About Compugen
    
    
      Compugen’s mission is to be the world leader 
      in the discovery and licensing of product candidates to the drug and 
      diagnostic industries under milestone and revenue sharing agreements. 
      The Company’s increasing inventory of powerful 
      and proprietary discovery platforms is enabling the predictive discovery – 
      field after field – of numerous therapeutic 
      and diagnostic product candidates. These discovery platforms are based 
      on the Company’s decade-long focus on the 
      predictive understanding of important biological phenomena at the 
      molecular level. Compugen’s current 
      collaborations include Biosite, Medarex, Inc., Merck & Co., Inc., 
      Ortho-Clinical Diagnostics (a Johnson & Johnson company), Roche, Siemens 
      Healthcare Diagnostics, Inc., and Teva Pharmaceutical Industries. In 
      2002, Compugen established an affiliate – 
      Evogene Ltd. (TASE:EVGN.TA) – to utilize the 
      Company’s in-silico predictive 
      discovery capabilities in the agricultural biotechnology field. For 
      additional information, please visit Compugen's corporate Website at www.cgen.com 
      and Evogene’s corporate Website at www.evogene.com.